A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor

NCT04964375 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: ABSK043 oral capsule

Sponsor

Abbisko Therapeutics Co, Ltd